Type 1 Diabetes (T1D): Clinical Trials

96 trials for Type 1 Diabetes (T1D), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 recruiting, 20 not yet recruiting, 14 completed, 6 enrolling by invitation. 52 Not applicable, 8 Phase 2, 4 Phase 1, 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable52Recruiting 27, Not yet recruiting 12, Completed 6, Active not recruiting 4, Enrolling by invitation 2, Withdrawn 1
Phase 28Recruiting 4, Completed 2, Not yet recruiting 2
Phase 14Recruiting 3, Not yet recruiting 1
Phase 33Not yet recruiting 2, Recruiting 1
Phase 42Completed 1, Unknown 1

Follow Type 1 Diabetes (T1D): new trials by email Literature Review of Type 1 Diabetes (T1D) trials Research Report on Type 1 Diabetes (T1D)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CKM For Safe Use of SGLT2i in Type 1 Diabetes
Sotagliflozin Low Dose, Sotagliflozin High Dose, Dual Continuous Glucose and Ketone Monitor - Type 1 Diabetes (T1D)
Phase 3Not yet recruitingUniversity of California, San Diego522027-04-012026-11-04
Technology Knowledge Optimization for Type 1 Diabetes in Schools
TeKnO T1D curriculum - Type 1 Diabetes (T1D)
Not applicableNot yet recruitingUniversity of Pittsburgh862027-02-012026-03-19
Functional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 Diabetes
Resistance exercise - Type 1 Diabetes (T1D), Menopause
Not applicableNot yet recruitingInstitut de Recherches Cliniques de Montreal632026-12-012026-10-01
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
NMX8 System - Treatment arm, AID Therapy, NMX8 System - Control Arm - Type 1 Diabetes (T1D)
Not applicableNot yet recruitingMedtronic MiniMed, Inc.2302026-10-152026-04-28
Food Prescription Among Youth With Type 1 Diabetes
Healthy Eating Program - Type 1 Diabetes (T1D)
Not applicableNot yet recruitingBaylor College of Medicine452026-10-012026-10-06
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems
Open-Source Automated Insulin Delivery (OS-AID), Commercial Automated Insulin Delivery (C-AID) - Type 1 Diabetes (T1D)
Not applicableNot yet recruitingInstitut de Recherches Cliniques de Montreal332026-10-012026-08-11
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Cadisegliatin 800 mg QD, Placebo - Type 1 Diabetes (T1D)
Phase 2Not yet recruitingvTv Therapeutics402026-10-012026-09-21
Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation
beta2score - Type 1 Diabetes (T1D)
Not yet recruitingUniversity Hospital, Strasbourg, France252026-09-012026-09-10
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
SAB-142, Placebo - Type 1 Diabetes (T1D)
Phase 3Not yet recruitingUniversity of Florida1082026-09-012026-06-26
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
AMX0035, Placebo - Type 1 Diabetes (T1D), Metabolic Diseases
Phase 2RecruitingUniversity of Washington602026-09-012026-09-15
Integrating New Skills Into Diabetes Education With CGM
Three-stage CGM integration program, One-time clinic-based CGM training, Self-directed CGM training - Insulin Dependent Diabetes, Diabetes (DM)
Not applicableRecruitingUniversity of North Carolina, Chapel Hill1442026-08-112026-10-05
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Golimumab, Placebo (matching golimumab) - Type 1 Diabetes (T1D)
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2552026-08-082026-07-06
Adapting Single Sessions Interventions for Type 1 Diabetes
T1D-specific depression SSI, T1D Educational - Type 1 Diabetes (T1D)
Not applicableRecruitingNemours Children's Health System802026-08-032026-07-24
Finding Immune Nascent Type 1 Diabetes
phone call, email/mail - Healthy Adult, Type 1 Diabetes (T1D)
Not applicableRecruitingIndiana University38002026-07-282026-10-02
Universal Type 1 Diabetes Screening in Pediatrics
Set of implementation strategies - Type 1 Diabetes (T1D)
Enrolling by invitationNorthwestern University95002026-07-172026-10-15
App-Based Certified Diabetes Education Therapy (AB-CDE)
DailyDose - Type 1 Diabetes (T1D)
Not applicableRecruitingOregon Health and Science University992026-07-082026-09-23
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes
Moderate carbohydrate restriction, Early time-restricted eating, Standard calorie restriction - Type 1 Diabetes (T1D), Obesity & Overweight
Not applicableRecruitingFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud752026-07-022026-07-15
Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes
Temporary Insulin Suspension, Glucose and ketone sensor - Type 1 Diabetes (T1D)
Not applicableNot yet recruitingMahla Poudineh102026-06-302026-05-05
Pilot of Food Is Medicine Interventions to Reduce Cardiovascular Disease Risk in Children With Food Insecurity and Diabetes
Produce prescription, Medically tailored meal kits, Nutrition Coaching - Type 1 Diabetes (T1D), Food Insecurity
Not applicableNot yet recruitingKatelyn Fox122026-05-302026-05-15
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
MODI Algorithm - Type 1 Diabetes (T1D), Type 2 Diabetes (T2D)
Not applicableRecruitingDreaMed Diabetes1022026-05-252026-08-28

Showing 20 of 96. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 1 (96)  ·  Diabetes Mellitus (10)  ·  Insulin Resistance (9)  ·  Diabetes Mellitus, Type 2 (6)  ·  Motor Activity (6)  ·  Autoimmune Diseases (3)  ·  Glucose Intolerance (3)  ·  Obesity (3)  ·  Depression (2)  ·  Glucose Metabolism Disorders (2)  ·  Hypoglycemia (2)  ·  Immune System Diseases (2)  ·  Metabolic Diseases (2)  ·  Overweight (2)  ·  Renal Insufficiency, Chronic (2)

Broader conditions

Endocrine System Diseases (95)  ·  Nutritional and Metabolic Diseases (95)  ·  Glucose Metabolism Disorders (94)  ·  Immune System Diseases (94)  ·  Metabolic Diseases (94)  ·  Autoimmune Diseases (93)  ·  Diabetes Mellitus (86)  ·  Behavior (13)  ·  Hyperinsulinism (9)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Disease Attributes (4)  ·  Pathologic Processes (4)  ·  Signs and Symptoms (4)  ·  Behavioral Symptoms (3)  ·  Body Weight (3)

Interventions

Continuous Glucose Monitoring (2)  ·  Early Intervention, Educational (2)  ·  Exercise (2)  ·  Resistance Training (2)  ·  (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)  ·  Blood Glucose Self-Monitoring (1)  ·  Community Health Workers (1)  ·  Continuous Positive Airway Pressure (1)  ·  Cyclosporine (1)  ·  Drug Delivery Systems (1)  ·  Exercise Test (1)  ·  Insemination, Artificial, Heterologous (1)  ·  Insulin (1)  ·  Insulin Glargine (1)  ·  Melatonin (1)

Sponsors

Institut de Recherches Cliniques de Montreal (3)  ·  University of Florida (3)  ·  Dasman Diabetes Institute (2)  ·  Hospital Universitario San Ignacio (2)  ·  Life for a Child Program, Diabetes Australia (2)  ·  Royal Devon and Exeter NHS Foundation Trust (2)  ·  University Hospital, Grenoble (2)  ·  University Hospital, Strasbourg, France (2)  ·  University of Colorado, Denver (2)  ·  University of Oxford (2)  ·  University of Pittsburgh (2)  ·  University of Virginia (2)  ·  Yale University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Adhera Health, Inc. (1)

Countries

United States (36)  ·  France (7)  ·  Italy (7)  ·  Spain (7)  ·  United Kingdom (7)  ·  Canada (5)  ·  China (3)  ·  Germany (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Colombia (2)  ·  Denmark (2)  ·  India (2)  ·  Kuwait (2)  ·  Argentina (1)

Top investigators

Ebaa Al Ozairi, MD (2)  ·  Michael Haller (2)  ·  Aleix Beneyto (1)  ·  Ali Naji, PhD (1)  ·  Andrew Posselt, MD, PhD (1)  ·  Anna Kahkoska, MD, PhD (1)  ·  Anna Prats (1)  ·  Bernhard Hering, MD (1)  ·  Camillo Ricordi, MD (1)  ·  Christine A March, MD, MS (1)  ·  Dorota Zozulinska-Ziolkiewicz, MD, PhD (1)  ·  Dr. Sonali S Wagle, M.Sc, RD, PhD (1)

Results publications

PMID 19481250, PMID 25191067, PMID 26347009, PMID 26989414, PMID 28895431, PMID 29563012, PMID 30159091, PMID 30224348, PMID 30369949, PMID 31689561, PMID 32431669, PMID 33687783, PMID 35403792, PMID 36058207, PMID 36120658, PMID 36183355, PMID 36299323, PMID 36384715, PMID 36444686, PMID 36598841, PMID 36830822, PMID 38377327, PMID 38847967, PMID 40755960, PMID 41184866, PMID 41548712, PMID 42172625, PMID 42579799, PMID 42666156, PMID 42767751, PMID 42829215

NIH funding

2025 (2), K01DK129441 (1), K12DK133995 (1), K23DK131342 (1), K23DK139431 (1), R01DK085623 (1), R01DK121130 (1), R01DK129553 (1), R01DK137859 (1), R01DK140212 (1), R01HL174685 (1), R01HL174735 (1), R01HL174738 (1), R21NR022207 (1), R34DK136020 (1)